Original Research
Published on 20 Sep 2024
Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1422206
- 1,942 views
Type at least 3 characters
6,674 articles
Articles
Review
Published on 20 Sep 2024
CD8+ T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1476904
- 1,690 views
Systematic Review
Published on 20 Sep 2024
Prognostic implications of tumor-infiltrating lymphocytes in non-small cell lung cancer: a systematic review and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1476365
- 801 views
Original Research
Published on 20 Sep 2024
Cytosolic nucleic acid sensors and interferon beta-1 activation drive radiation-induced anti-tumour immune effects in human pancreatic cancer cells
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1286942
- 1,930 views
Editorial
Published on 20 Sep 2024
Editorial: Implications of immune landscape in tumor microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1491644
- 556 views
Review
Published on 20 Sep 2024
RNA modifications in cancer immune therapy: regulators of immune cells and immune checkpoints
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1463847
- 1,176 views
Original Research
Published on 19 Sep 2024
CCL4 as a potential serum factor in differential diagnosis of central nervous system inflammatory diseases and gliomas
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1461450
- 921 views
Original Research
Published on 19 Sep 2024
Multi-omics profiling and experimental verification of tertiary lymphoid structure-related genes: molecular subgroups, immune infiltration, and prognostic implications in lung adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1453220
- 1,296 views
Original Research
Published on 19 Sep 2024
High specificity of engineered T cells with third generation CAR (CD28-4-1BB-CD3-ζ) based on biotin-bound monomeric streptavidin for potential tumor immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1448752
- 1,117 views
General Commentary
Published on 19 Sep 2024
Commentary: Immune cell infiltration and prognostic index in cervical cancer: insights from metabolism-related differential genes
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1446741
- 399 views
Original Research
Published on 19 Sep 2024
Machine learning to predict distant metastasis and prognostic analysis of moderately differentiated gastric adenocarcinoma patients: a novel focus on lymph node indicators
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1398685
- 1,023 views
Review
Published on 19 Sep 2024
Traditional Chinese herbal medicine: harnessing dendritic cells for anti-tumor benefits
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1408474
- 868 views
Original Research
Published on 18 Sep 2024
Chemotherapy combined with regorafenib and immune checkpoint inhibitors as a first-line treatment for patients with advanced biliary tract cancer: a single arm phase II trial
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1449211
- 937 views
Review
Published on 18 Sep 2024
Research progress on ferroptosis in colorectal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1462505
- 1,274 views
Review
Published on 18 Sep 2024
Unlocking the tumor-immune microenvironment in osteosarcoma: insights into the immune landscape and mechanisms
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1394284
- 1,495 views
Systematic Review
Published on 18 Sep 2024
Evaluation of the efficacy and safety of first- and second-line immunotherapy in patients with metastatic colorectal cancer: a systematic review and network meta-analysis based on randomized controlled trials
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1439624
- 1,260 views